Patent · US Expired

Method for chromosomal rearrangement by consecutive gene targeting of two recombination substrates to the deletion endpoints

US6077667A · kind A · utility

5Cited by
1References
19Claims
0Family size

Inventors

Key dates

Filing dateJun 26, 1997
Grant dateJun 20, 2000
Priority date
Expiry dateJun 26, 2017

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2800/30
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention involves the creation of defined chromosomal deficiencies, inversions and duplications using Cre recombinase in ES cells transmitted into the mouse germ line. These chromosomal reconstructions can extend up to 3-4 cM. Chromosomal rearrangements are the major cause of inherited human disease and fetal loss. Additionally, translocations and deletions are recognized as major genetic changes that are causally involved in neoplasia. Chromosomal variants such as deletions and inversions are exploited commonly as genetic tools in organisms such as Drosophila. Mice with defined regions of segmental haploidy are useful for genetic screening and allow accurate models of human chromosomal diseases to be generated.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.